scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1031229783 |
P356 | DOI | 10.1038/SJ.GT.3301530 |
P698 | PubMed publication ID | 11571583 |
P5875 | ResearchGate publication ID | 11775865 |
P50 | author | Jay T. Evans | Q59952549 |
P2093 | author name string | Lipsky PE | |
Kelly PF | |||
Gatlin J | |||
Garcia JV | |||
Cravens P | |||
P2860 | cites work | Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions | Q40881143 |
Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors. | Q40944037 | ||
Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors. | Q40957529 | ||
High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells | Q40972867 | ||
Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 | Q43662819 | ||
In vivo selection of retrovirally transduced hematopoietic stem cells | Q45889578 | ||
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells | Q46578425 | ||
Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. | Q54134810 | ||
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. | Q54212663 | ||
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
Thymocyte differentiation from lentivirus-marked CD34(+) cells in infant and adult human thymus | Q73103570 | ||
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers | Q27730413 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
The dendritic cell system and its role in immunogenicity | Q29619870 | ||
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity | Q36366051 | ||
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines | Q36366108 | ||
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo | Q36366124 | ||
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity | Q36366130 | ||
Transfer and expression of the human multiple drug resistance gene into live mice | Q37249173 | ||
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection | Q40342080 | ||
Differentiation and expansion of lentivirus vector-marked dendritic cells derived from human CD34(+) cells | Q40734572 | ||
In vitro selection of lentivirus vector-transduced human CD34+ cells | Q40748112 | ||
Nucleoside transport in normal and neoplastic cells | Q40837882 | ||
P433 | issue | 18 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 1427-1435 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells | |
P478 | volume | 8 |
Q45855908 | Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells |
Q40632521 | High-Level Expression of Cancer/Testis Antigen NY-ESO-1 and Human Granulocyte-Macrophage Colony-Stimulating Factor in Dendritic Cells with a Bicistronic Retroviral Vector |
Q41679126 | Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells |
Q24792158 | In vitro correction of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique. |
Q35120825 | Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option? |
Search more.